Giardiasis

Giardiasis
Other namesBeaver fever, giardia
Giardia cell viewed with scanning electron microscope
SpecialtyInfectious disease, gastroenterology
SymptomsDiarrhoea, abdominal pain, weight loss, nausea
Usual onset1 to 3 weeks after exposure
CausesGiardia duodenalis spread mainly through contaminated food or water
Risk factorsHypogammaglobulinemia
Diagnostic methodStool testing
Differential diagnosisIrritable bowel syndrome
PreventionImproved sanitation
TreatmentAntiprotozoal medications
MedicationTinidazole, metronidazole
FrequencyUp to 7% (developed world), up to 30% (developing world)

Giardiasis is a parasitic disease caused by the protist enteropathogen Giardia duodenalis (also known as G. lamblia and G. intestinalis), especially common in children and travelers. Infected individuals experience steatorrhea, a type of diarrhea with fatty sticky stool; abdominal pain, weight loss, and weakness due to dehydration and malabsorption. Less common symptoms include skin rash, hives and joint swelling. Symptoms usually begin one to three weeks after exposure and, without treatment, may last two to six weeks or longer. Some infected individuals experience mild or no symptoms and remain symptom-free even if infection persists for a long time.

Giardiasis spreads via the fecal-oral route, when Giardia cysts excreted with feces contaminate food or water that is later consumed orally. The disease can also spread between people and between people and animals, mainly via pets. Cysts may survive for nearly three months in cold water.

The microscopic identification of Giardia and its cysts in fecal samples is considered as the gold standard method for the diagnosis of giardiasis. Immunoassays, such as ELISA, and PCR for giardia gene loci are also available as diagnostic tools, although are not widely used due to methods complexity and costs.

Prevention may be improved through proper personal hygiene practices, by cooking and sanitizing food. Asymptomatic cases often do not need treatment. When symptoms are present, treatment is typically provided with either tinidazole or metronidazole. Other drugs, such as nitazoxanide, albendazole, quinacrine, chloroquine, paromomycin and drug combinations are also used in clinics. Refractory giardiasis and resistant strains are reported more and more often. Infection may cause a person to become lactose intolerant, so it is recommended to temporarily avoid lactose following an infection or use lactase supplements.

Giardiasis occurs worldwide. It is one of the most common parasitic human diseases. Infection rates are as high as 7% in the developed world and 30% in the developing world. In 2013, there were approximately 280 million people worldwide with symptomatic cases of giardiasis. The World Health Organization classifies giardiasis as a neglected disease. It is popularly known as beaver fever in North America.